BioTelemetry (BEAT) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results
February 22, 2018 4:05 PM ESTCompany Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations
MALVERN, Pa., Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter ended December 31, 2017.
Company Highlights
Recognized highest quarterly revenue in Companys history of $91.7 millionAchieved 10% organic revenue growthAchieved 22nd consecutive quarter of year over year... More